Humana (NYSE:HUM) Shares Down 6.2% – Here’s What Happened

by · The Cerbat Gem

Humana Inc. (NYSE:HUM – Get Free Report)’s share price dropped 6.2% during mid-day trading on Tuesday . The stock traded as low as $256.51 and last traded at $257.5890. Approximately 2,122,374 shares changed hands during trading, an increase of 21% from the average daily volume of 1,754,275 shares. The stock had previously closed at $274.74.

Wall Street Analyst Weigh In

HUM has been the subject of a number of research analyst reports. Truist Financial cut their price objective on Humana from $300.00 to $285.00 and set a “hold” rating for the company in a research report on Monday, November 10th. Guggenheim reissued a “buy” rating on shares of Humana in a research note on Friday, October 3rd. Wolfe Research reduced their price objective on Humana from $313.00 to $300.00 and set an “outperform” rating on the stock in a research note on Thursday, November 20th. The Goldman Sachs Group decreased their price objective on Humana from $235.00 to $215.00 and set a “sell” rating on the stock in a report on Monday, November 24th. Finally, Bank of America raised their target price on shares of Humana from $280.00 to $300.00 and gave the company a “neutral” rating in a report on Friday, October 10th. Nine investment analysts have rated the stock with a Buy rating, ten have issued a Hold rating and two have issued a Sell rating to the stock. Based on data from MarketBeat.com, the stock presently has an average rating of “Hold” and an average price target of $295.11.

Get Our Latest Stock Report on Humana

Humana Stock Down 6.0%

The company’s 50 day moving average is $261.98 and its 200 day moving average is $258.82. The company has a market cap of $31.05 billion, a PE ratio of 24.20, a P/E/G ratio of 1.57 and a beta of 0.46. The company has a current ratio of 2.02, a quick ratio of 2.02 and a debt-to-equity ratio of 0.68.

Humana (NYSE:HUM – Get Free Report) last released its quarterly earnings data on Wednesday, November 5th. The insurance provider reported $3.24 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.95 by $0.29. The company had revenue of $32.65 billion during the quarter, compared to analysts’ expectations of $31.99 billion. Humana had a net margin of 1.02% and a return on equity of 12.86%. The firm’s quarterly revenue was up 11.1% on a year-over-year basis. During the same period in the previous year, the company earned $4.16 EPS. As a group, analysts predict that Humana Inc. will post 16.47 earnings per share for the current fiscal year.

Humana Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 30th. Shareholders of record on Friday, December 26th will be issued a dividend of $0.885 per share. This represents a $3.54 annualized dividend and a yield of 1.4%. The ex-dividend date is Friday, December 26th. Humana’s dividend payout ratio (DPR) is presently 33.18%.

Hedge Funds Weigh In On Humana

A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Elevation Point Wealth Partners LLC bought a new stake in shares of Humana in the second quarter valued at about $32,000. Mather Group LLC. purchased a new position in Humana during the 3rd quarter valued at about $34,000. AlphaCore Capital LLC bought a new stake in shares of Humana in the 2nd quarter valued at about $39,000. Private Wealth Management Group LLC lifted its position in shares of Humana by 47.5% in the 3rd quarter. Private Wealth Management Group LLC now owns 149 shares of the insurance provider’s stock worth $39,000 after purchasing an additional 48 shares during the period. Finally, Larson Financial Group LLC boosted its stake in shares of Humana by 114.1% during the third quarter. Larson Financial Group LLC now owns 152 shares of the insurance provider’s stock valued at $40,000 after purchasing an additional 81 shares in the last quarter. Institutional investors own 92.38% of the company’s stock.

Humana Company Profile

(Get Free Report)

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.

Featured Articles